Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b study of SchistoShield in healthy adults in Burkina Faso and Madagascar
PACTR202307901658960Phase 1Completed
- Sponsor
- International Vaccine Institute
- Start
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 1, randomised, single-blind trial in schistosomiasis comparing SchistoShield dose-escalation with Placebo (2 arms). Started Aug 2023; status: completed.
02
Drugs
SchistoShield
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on PACTR202307901658960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202307901658960.